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H YPOCAPNIA induced by hyperventilation and associated alkalosis have a wide range of physiologi-
cal effects, including increased cerebrovascular resistance 
(CVR), decreased cerebral blood flow (CBF), cerebral oxygen 
delivery (cDO2), and cerebral metabolism.
1 Despite routine 
end-tidal carbon dioxide monitoring, periods of inadvertent 
hyperventilation occur frequently during mechanical ven-
tilation under general anesthesia, which may be associated 
with unfavorable side effects such as cognitive dysfunction 
and increased length of hospital stay.2
Patients with Alzheimer disease are predisposed to post-
operative cognitive dysfunction. This group of patients has 
an increased vasoconstrictive response to hypocapnia and 
concomitantly a greater increase in oxygen extraction frac-
tion (OEF) than control patients.3 In patients with traumatic 
injury, vascular disorders, or meningitis, hyperventilation is 
associated with an impaired aerobic cerebral metabolism, 
reflected by an increase in net cerebral lactate efflux (cerebral 
metabolic rate [CMR] of lactate [CMRL]).4–8
However, until now there are only few studies describ-
ing the interrelation between hyperventilation and CMRL 
in animals and humans without cerebral diseases, and their 
results have not been consistent. A recent report about 
moderate and profound hyperventilation in anesthetized 
young pigs without cerebral disorder showed a reduction 
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ABSTRACT
Background: Hyperventilation is known to decrease cerebral blood flow (CBF) and to impair cerebral metabolism, but the 
threshold in patients undergoing intravenous anesthesia is unknown. The authors hypothesized that reduced CBF associated 
with moderate hyperventilation might impair cerebral aerobic metabolism in patients undergoing intravenous anesthesia.
Methods: Thirty male patients scheduled for coronary surgery were included in a prospective, controlled crossover trial. 
Measurements were performed under fentanyl-midazolam anesthesia in a randomized sequence aiming at partial pressures 
of carbon dioxide of 30 and 50 mmHg. Endpoints were CBF, blood flow velocity in the middle cerebral artery, and cerebral 
metabolic rates for oxygen, glucose, and lactate. Global CBF was measured using a modified Kety–Schmidt technique with 
argon as inert gas tracer. CBF velocity of the middle cerebral artery was recorded by transcranial Doppler sonography. Data 
were presented as mean (SD). Two-sided paired t tests and one-way ANOVA for repeated measures were used for statistical 
analysis.
Results: Moderate hyperventilation significantly decreased CBF by 60%, blood flow velocity by 41%, cerebral oxygen deliv-
ery by 58%, and partial pressure of oxygen of the jugular venous bulb by 45%. Cerebral metabolic rates for oxygen and glucose 
remained unchanged; however, net cerebral lactate efflux significantly increased from −0.38 (2.18) to −2.41(2.43) µmol min−1 
100 g−1.
Conclusions: Moderate hyperventilation, when compared with moderate hypoventilation, in patients with cardiovascular 
disease undergoing intravenous anesthesia increased net cerebral lactate efflux and markedly reduced CBF and partial pressure 
of oxygen of the jugular venous bulb, suggesting partial impairment of cerebral aerobic metabolism at clinically relevant levels 
of hypocapnia. (Anesthesiology 2014; 120:335–42)
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in regional CBF and oxygen availability, resulting in tissue 
hypoxia as reflected by an increase in markers of anaerobic 
metabolism.9 Similarly, investigations using magnetic reso-
nance spectroscopy or the Kety–Schmidt technique in awake 
volunteers undergoing hyperventilation showed an increase 
in net cerebral lactate efflux.8,10,11
The anesthetized brain might be less vulnerable to isch-
emia than the nonanesthetized brain as the induction of 
anesthesia reduces cerebral electric activity, metabolism, 
and flow.1 In humans, induction of intravenous anesthesia 
even may reduce cerebral lactate efflux.12–14 But moderate 
hyperventilation during anesthesia also showed a trend to 
increase net cerebral lactate efflux though not reaching sig-
nificance.13,15,16 The relevance of this finding, however, may 
be limited, because of the small number of patients, which 
have been included in these studies.
The interrelation between moderate variations in PaCO2, 
CVR, CBF, global cDO2, and cerebral metabolism in patients 
undergoing intravenous anesthesia is thus not fully understood.
We therefore investigated the effects of variation in 
arterial carbon dioxide partial pressure on cerebral hemo-
dynamics and metabolism in 30 cardiac surgical patients 
undergoing intravenous anesthesia. We hypothesized that 
moderate hyperventilation, when compared with moderate 
hypoventilation, will reduce CBF and cDO2 to an extent 
which might impair cerebral aerobic metabolism.
Materials and Methods
Design
The prospective study was designed and performed in a 
controlled, crossover design at the University of Göttingen 
Medical Center aiming at changes in CBF, CBF velocity 
(V), and the metabolic effects of hyper- versus hypoventila-
tion in anesthetized patients. Each patient served as his own 
control. Approval was obtained from the local institutional 
review board (Medical Ethical Committee of the Georg-
August-University of Göttingen, Göttingen, Niedersachsen, 
Germany; No. 07/09/90). Study period was 27 months 
(February 20, 1991 until May 10, 1993).
Endpoints
The primary endpoints of the trial were changes in CBF, blood 
flow velocity of the middle cerebral artery (VMCA), cDO2, 
CMRL, CMR of oxygen (CMRO2), and CMR of glucose. The 
secondary endpoints were changes in cerebral zero-flow pressure 
(ZFP), effective cerebral perfusion pressure (CPPeff), and CVR.
Screening and Inclusion of Patients
Due to logistic reasons, we could perform only 1–2 mea-
surements per month. Thus, standard screening procedures 
could not be applied in this crossover trial. Patients were eli-
gible for inclusion if scheduled for elective coronary surgery. 
Exclusion criteria were being older than 80 yr of age, female 
sex, patient refusal, active neurological disease, and a his-
tory of cerebrovascular disease, brain injury, or intracranial 
surgery. All patients were informed of the purpose of the 
study and provided written informed consent before being 
enrolled. None of the eligible patients refused inclusion of 
the trial. There were no dropouts during the study period.
Sample Size Calculation
The intersubject and intrasubject variability of CBF and 
cerebral lactate metabolism has been reported in earlier stud-
ies.10,13,15,16 However, there was a lack of data regarding the 
variance of the CMRL measurement method in anesthetized 
patients, which was necessary for an exact sample size calcula-
tion for this crossover trial. We expected a 50% difference of 
CMRL with an estimated effect size of 0.7–0.8. For a statistical 
power of 0.8–0.9, the sample size had to be between 24 and 30 
patients. Therefore, we projected a sample size of 30 patients.
Anesthesia Procedure
Individual medications were continued until surgery. Anes-
thesia was induced by intravenous administration of 7 µg/kg 
of fentanyl, 0.2 mg/kg of midazolam, and 0.1 mg/kg of pan-
curonium. Anesthesia was maintained with 10 µg·kg−1·h−1 
of fentanyl and 150 µg·kg−1·h−1 of midazolam. The anes-
thesia procedure, the details of mechanical ventilation, and 
the methods of insertion of catheters have been described in 
detail in a previous report.14
Measurements
Cerebral blood flow was measured with the use of modi-
fied Kety–Schmidt inert gas saturation technique with argon 
as a tracer gas.14,17,18 The wash-in period was 10 min. Blood 
samples were obtained simultaneously from the arterial and 
jugular bulb catheters at a constant rate of 0.5 ml/min by 
a high-precision aspiration pump with gas-tight Hamilton 
glass syringes. The withdrawal rate for probes of the argon 
end-concentration was 5 ml/20 s. A brain–blood partition 
coefficient of 1.10 was used to calculate CBF.19,20
Blood flow velocity in the proximal (M1) segment of the 
MCA was measured by transcranial Doppler sonography as 
extensively described in earlier reports.14,21,22 Because tran-
scranial Doppler measurements of VMCA from the transtem-
poral window fail with above average incidence in elder female 
patients, we included only male patients in this study.23,24
Measurements were performed at two different PaCO2 
levels, approximately 50 and 30 mmHg, in a randomized 
sequence before surgery. All measurements were performed 
during hemodynamic and respiratory steady-state condi-
tions. The time interval between the measurements was 
20 min. Blood samples were drawn twice, at the beginning 
and end of each argon wash-in period, to measure hemo-
globin concentration, blood gas analysis (ABL; Radiometer, 
Copenhagen, Denmark), and blood glucose and lactate con-
centrations (enzymatic tests kids; Boehringer, Mannheim, 
Germany). For comparisons with CBF measurements, 
VMCA was averaged during the 10-min period of each argon 
wash-in maneuver. End-expiratory concentrations of carbon 
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dioxide were continuously recorded to ensure a stable PaCO2 
during argon saturation.
Calculations
Cerebral ZFP was calculated at the beginning and end of 
each CBF measurement from two simultaneous 10-s record-
ings (two breathing cycles) of the VMCA envelope and arterial 
pressure curves. During each 10-s period, we first averaged 
diastolic, mean, and systolic data of arterial blood pressure 
(ABP) and VMCA to obtain a pressure–flow velocity plot. 
Cerebral ZFP was then extrapolated by linear regression anal-
ysis of the ABP–VMCA relationship. The ABP axis intercept of 
the regression line determines the ZFP.22,25 The cerebral ZFP 
was used as a measure of the effective downstream pressure 
of the cerebral circulation. Consequently, CPPeff and CVR 
were calculated as CPPeff = mean ABP − ZFP and CVR = 
CPPeff·CBF
−1, respectively. Cerebrovascular CO2 reactivity 
was calculated from the slope of the linear regression line of 
the relationship between CBF and PaCO2 as well as VMCA and 
PaCO2. Relative CO2 reactivity was calculated as the percent-
age of change in CBF or VMCA per mmHg change in PaCO2.
26
CMRO2, CMR of glucose, and CMRL were calculated 
based on the reversed Fick principle, multiplying CBF by 
the difference in arterio-jugular venous content of oxygen 
(AJVDO2), lactate (AJVDL), and glucose.
8 By definition, 
positive CMR values indicate consumption or net influx, 
and negative values indicate production or net efflux. For 
AJVDL and CMRL, we thus expected negative values in case 
of cerebral lactate production.
The OEF was calculated as the ratio between AJVDO2 
and arterial oxygen content. The lactate–oxygen index (LOI), 
which relates cerebral lactate production to oxygen extrac-
tion, was defined as LOI [] = AJVDL [mM] AJVDO2
−1 [mM]. 
The lactate–glucose index (LGI), that is, the fraction of glu-
cose consumption that is metabolized and excreted from 
brain as lactate, was defined as the ratio between the arterio-
jugular venous content differences of lactate and glucose. For 
these calculations, contents of oxygen and glucose concentra-
tions have been converted in to mM. Because one molecule of 
glucose is metabolized to two molecules of lactate, an LGI of, 
for example, −0.1 indicates, that 5% of the cerebral glucose 
consumption have been metabolized to lactate.5,8,27
Statistical Analysis
The results presented in tables are expressed as mean (SD) 
unless otherwise stated. To provide an estimate of the effect 
of hypocapnia and its clinical meaningfulness, we calcu-
lated mean differences (MD) and their 95% CIs (MD; 95% 
CI, lower bound, upper bound; P value).28 The difference 
between hyperventilation and hypoventilation was calcu-
lated using t tests for paired data or Welch test and nonpara-
metric Wilcoxon signed-rank tests, if indicated. To prevent 
from type I error inflation, all primary endpoints were tested 
by one-way ANOVA for repeated measurements followed by 
Bonferoni multiple comparison tests. All statistical analyses 
were performed two-sided, and a P value of less than 0.05 
was considered to be significant.
Calculations were performed using SPSS 17 (IBM SPSS 
Statistics, Armonk, NY), and graphs were made using Prism 
6.0c (GraphPad Software, La Jolla, CA).
Sample size calculation was done with G*Power 3 (Uni-
versity of Düsseldorf, Department of Psychology, Düssel-
dorf, Germany).29
Results
A total of 30 male patients were included in the study. The 
mean age of the patients was 56(8) yr (median, 58; range, 
41–78 yr), mean height 173(6) cm, and mean body weight 
77(9) kg. In one patient, CBF could not be measured during 
hypoventilation, because of technical problems during jugu-
lar venous blood sampling. Hemodynamic and metabolic 
data are presented in table 1.
Due to the controlled adjustment of mechanical ven-
tilation, the variability of PaCO2 at both target levels was 
small. The blood temperature of the patients was effectively 
kept constant. Only one of our patients had diabetes mel-
litus. None of the patients showed increased levels of blood 
glucose.
The effects of ventilatory changes on the cerebral circu-
lation were substantial. Hyperventilation reduced CBF by 
60%, and VMCA by 41%, when compared with hypoven-
tilation. This reduction was predominantly caused by 
increased CVR (MD, 0.95; 95% CI, 0.75–1.11 mmHg·m
l−1·min−1·100 g−1; P < 0.001) and decreased CPPeff (−14%). 
The decrease in CPPeff during hyperventilation occurred 
because of a significant increase in the cerebral ZFP (MD, 
13; 95% CI, 9–16 mmHg; P < 0.001), which exceeded the 
small increase in mean arterial pressure (MD, 5; 95% CI, 
2–8 mmHg; P = 0.003). The decrease in CBF and cDO2 
(by 58%) during hyperventilation was associated with a 
pronounced decrease in the venous jugular bulb oxygen 
saturation (MD, 31; 95% CI, 34–28%; P < 0.001) and 
venous jugular bulb partial pressure of oxygen (PjvO2; 
MD, 21; 95% CI, 19–22 mmHg; P < 0.001; fig. 1). The 
cDO2/CMRO2 ratio changed from 4.5:1 to 1.8:1; that is, 
the OEF during hyperventilation markedly increased from 
0.24 to 0.57.
Mean arterial-jugular venous difference of oxygen, glu-
cose, and lactate changed significantly during moderate 
hyperventilation when compared with hypoventilation 
(table 1). The mean cerebral efflux of lactate significantly 
increased, by 2.0 µmol·min−1·100 g−1, whereas mean 
CMRO2 and CMR of glucose remained constant. LOI and 
LGI significantly decreased, that is, became more negative.
Cerebrovascular CO2 reactivity of CBF was 2.02 (1.18) 
ml·min−1·100–1·mmHg−1, corresponding to a relative change 
of 2.79 (0.77) %·mmHg−1. The cerebrovascular CO2 reac-
tivity of mean VMCA was 1.18 (0.48) cm·s
−1·mmHg−1, cor-
responding to a relative change of 2.03 (0.50) %·mmHg−1, 
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which was significantly lower than the relative CO2 reactivity 
of CBF (MD, −0.76; 95% CI, −0.96 to −0.56; P < 0.001).
Discussion
We investigated the effects of variations in arterial carbon 
dioxide partial pressure on cerebral hemodynamics and 
metabolism in cardiac surgical patients undergoing fentanyl 
or midazolam anesthesia. Compared with hypoventilation, 
moderate hyperventilation was associated with a signifi-
cant reduction in CBF, cDO2, and PjvO2. The mean cere-
bral efflux of lactate significantly increased, whereas mean 
CMRO2 and CMR of glucose remained constant.
Hyperventilation reduces PaCO2 and decreases extracel-
lular H+, leading to cerebral vasoconstriction and consecu-
tively to reduced CBF and cDO2.
1 An associated increase in 
net cerebral efflux of lactate at low PaCO2 levels in principle 
may be explained by different mechanisms:
•	 Dissociation of oxygen-binding curve to the left as a result 
of the respiratory alkalosis (Bohr effect)30–32
•	 Alkalosis induced change of redox systems of lactate/ pyruvate 
and NADH/NAD+,16,33–35 and
•	 Severe cerebral hypoperfusion with tissue hypoxia.9,36,37
Recent investigations on lactate kinetics and oxygenation using 
lactate isotopes demonstrate simultaneous lactate uptake and 
release in the brain.38 In addition to glucose and ketone bodies, 
lactate is also known to be an essential part of cerebral energy 
metabolism. Recent trials have shown that the glucose taken up 
by astrocytes is converted to lactate, and that the lactate released 
from astrocytes may be taken up by neurons and used as energy, 
especially in activated neurons, referred to as the astrocyte–
neuron lactate shuttle hypothesis.39 Thus, partial metabolic 
compartmentalization appears to exist between astrocytes and 
neurons, with astrocytes feeding the neurons with lactate gener-
ated from glycolysis upon cerebral activation.40
The magnitude of change in mean CMRL of our patients 
was 2.0 µmol·min−1·100 g−1, which was greater than expected. 
Previous studies have shown that absolute levels of CMRL may 
considerably vary depending on the group of patients and the 
Table 1. Hemodynamic and Metabolic Data during Moderate Changes in PaCo2 in Patients without Cerebral Disease with 
Intravenous Anesthesia
Parameters  
(n = 30) Units
Hyperventilation, 
Mean (SD)
Hypoventilation, 
Mean (SD)
Mean Differences  
(CI, 5%; 95%) P Value
PaCo2 mmHg 31 (3) 51 (3) 20 (19; 21) <0.001
CBF*† ml·min−1·100 g−1 27 (6) 68 (24) 41 (28; 53) <0.001
VMCA mean*† cm/s 34 (12) 58 (17) 24 (19; 28) <0.001
MAP mmHg 76 (12) 71 (11) −5 (−8; −2) 0.003
ZFP† mmHg 24 (9) 11 (11) −13 (−16; −9) <0.001
CPPeff mmHg 51 (11) 59 (14) 8 (4; 12) <0.001
CVR† mmHg·ml−1·min−1·100 g−1 1.93 (0.52) 0.95 (0.32) −0.95 (−1.11; −0.75) <0.001
Hb mg/dl 12.7 (1.5) 12.4 (1.4) −0.3 (−0.5; 1.0) 0.505
TempBlood °C 35.3 (0.4) 35.3 (0.5) −0.06 (−0.15; 0.03) 0.166
pHart — 7.48 (0.03) 7.30 (0.03) −0.18 (−0.19; −0.16) <0.001
Sao2† % 96 (1) 95 (2) −1.6 (−2.4; −0.7) <0.001
Sjvo2† % 41 (8) 72 (5) 31 (28; 34) <0.001
Pao2 mmHg 121 (31) 109 (28) −11 (−23; 0) 0.047
Pjvo2† mmHg 30 (9) 46 (5) 16 (13; 19) <0.001
AJVDo2† mg/dl 9.7 (1.6) 3.9 (0.9) −5.8 (−6.3; −5.3) <0.001
AJVDG mg/dl 11.2 (2.7) 5.6 (2.3) −5.6 (−4.4; −6.9) <0.001
AJVDL† mM −0.080 (0.079) −0.003 (0.033) 0.077 (0.047; 0.107) <0.001
cDo2*† ml·min
−1·100 g−1 4.61 (0.83) 11.08 (4.01) 6.49 (4.42; 8.51) <0.001
CMRo2* ml·min
−1·100 g−1 2.64 (0.68) 2.51 (0.77) −0.14 (−0.20; 0.48) >0.999
CMRG* mg·min−1·100 g−1 3.10 (1.23) 3.56 (1.49) 0.46 (1.43; 0.51) >0.999
CMRL* µmol·min−1·100 g−1 −2.41 (2.43) −0.38 (2.18) 2.03 (0.60; 3.48) 0.003
oEF — 0.57 (0.09) 0.24 (0.05) −0.34 (−0.36; −0.31) <0.001
LoI — −0.014 (0.014) −0.004 (0.016) 0.011 (0.004; 0.018) <0.001
LGI — −0.13 (0.13) −0.03 (0.15) 0.11 (0.04; −0.18) 0.003
The P values, which refer to the difference between hyperventilation and hypoventilation, were calculated using two-sided t test for paired data (n = 30).
* Statistical analyses of primary endpoints were adjusted by one-way ANoVA for repeated measurements with Bonferoni multiple comparison procedure 
(n = 29). † Because the variances of some outcome variables substantially differed between hyperventilation vs. hypoventilation, these parameters were 
additionally examined by Welch test and nonparametric Wilcoxon signed-rank tests, which showed that the differences persist.
AJVDG = arterio-jugular venous difference in glucose; AJVDL = arterio-jugular venous difference in lactate; AJVDo2 = arterio-jugular venous difference 
in oxygen; CBF = cerebral blood flow; cDo2 = cerebral oxygen delivery; CMRG = cerebral metabolic rate of glucose; CMRL = cerebral metabolic rate of 
lactate; CMRo2 = cerebral metabolic rate of oxygen; CPPeff = effective cerebral perfusion pressure; CVR = cerebrovascular resistance; Hb = hemoglobin 
concentration; LGI = lactate–glucose index; LoI = lactate–oxygen index; MAP = mean arterial pressure; oEF = oxygen extraction fraction; PaCo2 = arte-
rial partial pressure of carbon dioxide; Pao2 = arterial partial pressure of oxygen; pHart = negative logarithm of H
+ concentration (molarity) of arterial blood; 
Pjvo2 = jugular venous partial pressure of oxygen; Sao2 = arterial blood saturation; Sjvo2 = venous blood saturation of the jugular bulb; TempBlood = blood 
temperature; VMCA mean = mean blood flow velocity of the middle cerebral artery; ZFP = zero-flow pressure.
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level of consciousness.14,15,41,42 Absolute values of net cerebral 
lactate efflux in our patients thus have to be interpreted with 
care. A slight lactate efflux at hypocapnia may not necessarily 
indicate tissue hypoxia. However, the increase in AJVDL and 
net cerebral lactate efflux associated with hypocapnia and the 
concomitant decrease in CBF might be suspicious for anaero-
bic metabolism in relatively ischemic brain regions.
It seems unlikely that the increase of net cerebral lactate 
efflux at low PaCO2 levels might solely be caused by alkalosis-
induced enzymatic effects. There are no oxygen stores in the 
brain in contrast to myoglobin which stores oxygen in the 
muscle. Thus, the rate of oxygen delivery from the blood 
to brain tissue critically depends on the vessel-to-tissue oxy-
gen partial pressure (PtiO2) gradient and the efficiency of 
oxygen transfer from the capillary bed.43,44 A definite isch-
emic threshold for brain tissue oxygenation has not yet been 
defined. Jones et al.45 demonstrated that CBF less than 18 
ml·min−1·100 g−1 in awake monkeys results in irreversible 
brain tissue infarction. Michenfelder et al.46 reported criti-
cal CBF values of approximately 10–20 ml·min−1·100 g−1 in 
patients with ischemic changes in electroencephalography 
during carotid endarterectomy. In awake humans under nor-
mocapnic conditions, the cDO2/CMRO2 ratio is approxi-
mately 3:1 corresponding to an OEF of 0.33.8,47 An OEF of 
greater than 0.4 in patients with traumatic head injury corre-
sponded to a critically increased microdialysis lactate/pyru-
vate ratio which might reflect a mismatch between substrate 
demand and delivery on a cellular level.48 In our patients, 
the OEF considerably exceeded the threshold of 0.4 dur-
ing hyperventilation, mainly caused by a reduction of cDO2 
while CMRO2 remained unchanged.
Most investigators have considered jugular venous PO2 
below 20 mmHg and tissue PO2 values below 10 mmHg 
as pathological. Clausen et al.9 showed that even moderate 
hyperventilation (PaCO2 = 30 mmHg) leads to a critical reduc-
tion of regional CBF below 18 ml·min−1·100 g−1 in 22% of 
observed pigs; the tissue oxygen pressure decreased below 10 
mmHg in 30% of the animals undergoing moderate hyper-
ventilation. Furthermore, recent investigations showed that 
the final diffusion gradient from the microcirculation to the 
Fig. 1. (A–D) Values of cerebral blood flow (CBF), jugular venous partial pressure of oxygen (Pjvo2), cerebral metabolic rate of 
oxygen (CMRo2), and lactate (CMRL) during moderate hyperventilation compared with moderate hypoventilation. Straight lines 
link individual values for each subject. Data are mean (SD) for each measurement. The P values, which refer to the difference 
between hyperventilation and hypoventilation, were calculated using two-sided t tests for paired data. P values of primary 
endpoints were adjusted by Bonferoni multiple comparisons procedure (*). PaCo2 = arterial partial pressure of carbon dioxide.
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mitochondria is quite small.49 Then, oxygen tension might 
play an essential role in mitochondrial cellular oxygen sens-
ing and oxygen-regulated gene expression in clinical situa-
tions of low cDO2.
50,51
Although net cerebral lactate efflux during hyperventila-
tion increased in our patients, CMRO2 did not significantly 
change. Similarly, several previous studies found a reduction 
of tissue or cerebral venous oxygen tensions during moder-
ate hyperventilation, but no decrease in CMRO2 could be 
demonstrated.8,10,15,16,52,53
In contrast, other investigations could demonstrate 
that hyperventilation leads to a substantial decrease in 
CMRO2
35,54 or tissue oxygen pressure.9 However, investiga-
tions on CBF and cerebral metabolism with variations of 
PaCO2 in anesthetized patients or volunteers without cerebral 
disease are scarce and also showed an unchanged CMRO2 
at moderately low PaCO2 levels.
8,13,15,55 The Kety–Schmidt 
method measures only global CBF and metabolism. In 
case of regional hypoperfusion with increased CMRO2 in 
other regions of the brain, global CMRO2 may be unaf-
fected. Only when global oxygen availability decreases 
below oxygen demand, CMRO2 will decrease. The results 
of our report demonstrate that moderate hyperventilation, 
when compared with hypoventilation, leads to a significant 
decrease in venous jugular bulb oxygen saturation, PjvO2, 
AJVDO2, CBF, and thus cDO2. Net cerebral lactate efflux 
increased, which was associated with more negative LOI and 
LGI. Thus, our data do not indicate a severely disordered 
energy metabolism after a short phase of moderate hyper-
ventilation, but it suggests that cerebral aerobic metabolism 
may partly be impaired. However, the clinical significance of 
these findings remains unclear, because in humans without 
cerebrovascular or traumatic brain injury detrimental effects 
of hyperventilation in terms of morphologic or histologic 
changes have not yet been demonstrated.
For the analysis of our data, different methodological 
aspects have to be considered.
First, the a priori sample size calculation was based on 
estimation of the effect size because of a lack of data regard-
ing CMRL. A post hoc calculation, however, showed a statis-
tical power of 97% (n = 30, α error probability = 0.05; effect 
size of 0.73).
Furthermore, the type of anesthesia may have potential 
influence on the results of our study. Induction of anesthesia 
with fentanyl and midazolam leads to a moderate but pro-
portional reduction in CBF and cerebral metabolism.12,14,56 
The cerebrovascular CO2 reactivity in our patients favorably 
compared with data in conscious patients. Although we thus 
have no reason to assume that intravenous anesthesia with 
fentanyl and midazolam per se may have affected the PCO2-
induced changes in CMRL in our patients, the results of 
this study cannot a priori be extrapolated to other types of 
anesthesia.
Similarly, the external validity of our data could be 
limited by the fact that our patients were suffering from 
coronary artery disease and concomitant asymptomatic cere-
brovascular disease cannot completely be excluded despite 
normal cerebrovascular CO2 reactivity. Therefore, the con-
clusions from our study results should be limited to this 
patient population.
The changes in CBF induced by hyperventilation and 
hypoventilation are related to changes in CVR and CPP. The 
calculation of these variables commonly requires measure-
ments of intracranial pressure. We used a minor invasive 
method to estimate cerebral ZFP and CPPeff by extrapolat-
ing pressure–flow velocity plots using recordings of ABP and 
VMCA. This technique, however, is well established and may 
even provide a more meaningful quantification of the cere-
bral downstream pressure than intracranial pressure, particu-
larly in the absence of intracranial hypertension.6,22,57,58 The 
finding that moderate hyperventilation leads to a small but 
significant reduction of CPPeff due to a significant increase 
in ZFP is in accordance with previous trials investigating the 
effects of hyperventilation on the effective downstream pres-
sure of the cerebral circulation.6,22,57,58
The Kety–Schmidt method has been considered a refer-
ence method for estimating global CBF.59–61 In contrast to 
positron emission tomography or single-photon emission 
computed tomography, the Kety–Schmidt technique is 
largely independent of assumptions regarding tracer kinet-
ics, but might slightly overestimate global CBF in case of 
incomplete cerebral tracer saturation. Because of the cross-
over design of our study, a slight systematic overestimation 
of CBF has minor importance for the interpretation of 
hemodynamic and metabolic changes.
In our investigation, we studied CBF and metabolism 
aiming at PaCO2 levels of 30 and 50 mmHg. We chose these 
PaCO2 levels because they roughly reflect the range of unin-
tended variations of PaCO2 that often occur in routine clinical 
practice. The lack of data during normocapnia is a potential 
limitation of our study. Individual extrapolation of CBF at 
a PaCO2 of 40 mmHg gave a mean CBF under normocap-
nia of 48 (10) ml·min−1·100 g−1. The absolute and relative 
CO2 reactivity of CBF is in accordance with previous stud-
ies on the cerebral circulation during general anesthesia. 
This underlines the validity of our hemodynamic measure-
ments.8,13,18,55,62 Interestingly, the relative cerebrovascular 
CO2 reactivity of CBF was significantly higher than cerebro-
vascular CO2 reactivity of VMCA. The most probable explana-
tion is that changes in PaCO2 do not only cause changes in 
vascular diameter at the arteriolar level but might also cause 
minor changes in diameter of the MCA, resulting in a slight 
systematic difference between relative changes in flow and 
flow velocity. A similar phenomenon previously had been 
described during hypothermic cardiopulmonary bypass.14
In conclusion, moderate hyperventilation, when com-
pared with hypoventilation, increased net cerebral lactate 
efflux and decreased LOI and LGI in cardiovascular patients 
undergoing fentanyl–midazolam anesthesia. These metabolic 
changes suggest that the observed decrease in CBF, cDO2, 
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and PjvO2 may partly impair cerebral aerobic metabolism at 
clinically relevant levels of hypocapnia.
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